One of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for ... Read Full Story »
AbbVie Inc. (NYSE: ABBV) reported first-quarter 2013 results before markets opened this morning. The pharmaceutical research firm posted adjusted diluted earnings per share (EPS) of $0.68 on revenues of $4.33 ... Read Full Story »
U.S. equity markets opened higher this morning, but struggled to stay in positive territory for most of the morning. There was little economic data released today. In Asia, Hong Kong’s ... Read Full Story »
Investors and traders are on the lookout for fresh research ideas from Wall St. that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research ... Read Full Story »
With the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or ... Read Full Story »
U.S. equity markets opened flat this morning, largely due to a slew of data from Europe that essentially cancelled any good news with an equal dollop of bad. U.S. unemployment ... Read Full Story »
Have some widely owned health care names hit a wall when it comes to growth and earnings? In a research report issued today, Credit Suisse Group Inc. (NYSE: CS) issues ... Read Full Story »
These are some of this Thursday's top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AbbVie Inc. (NYSE: ABBV) started as Neutral at Credit Suisse. Akamai Technologies Inc. ... Read Full Story »
Stocks have rallied sharply during January after the last-minute congressional compromise on the fiscal cliff. While the deal was far from perfect, it averted not only a disaster for the ... Read Full Story »
After a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF) predict that 2013 could show more of the same. However ... Read Full Story »
China's services index rises to 56.1 in December, a sign of healthy expansion. (Reuters) Apple Inc. (NASDAQ: AAPL) tests a new iPhone and iOS 7. (Reuters) A court rejects an ... Read Full Story »